Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Maximizing patient recruitment using MyChart messages

Official title: Optimizing Strategies to Maximize Patient Recruitment Yield

Run by Emory University · NCT07290335 · Data updated 2026-11-12

This project tests whether different types of MyChart messages help health systems recruit more patients for research studies.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100000 (estimated)
SponsorEmory University
Academic / other
Locations1 site (Atlanta, Georgia)
StatusRecruiting
StartedFebruary 19, 2026
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedFebruary 25, 2026
Trial IDNCT07290335 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who receive MyChart recruitment messages and meet the eligibility criteria of a participating primary study are the intended participants.

Probably not a fit

Children/minors, patients excluded by the primary study, and people who do not use or receive MyChart messages are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This platform trial randomizes different MyChart messaging strategies—baseline (control), positively valenced, payment-inclusive, and combined positive-plus-payment—sent through the electronic health record patient portal to eligible patients. Participating primary studies must use the MyChart recruitment service and meet minimum message-volume criteria, and messages are allocated across arms to compare response and enrollment outcomes. Key measures include message open and click-through rates, consent/enrollment rates, and the representativeness of enrolled participants. The work is conducted within the Emory Healthcare system and includes all adults who receive MyChart recruitment messages for participating studies.

Why it matters

Potential benefit: If successful, this approach could increase enrollment rates, improve participant diversity, and reduce the time and cost needed to complete studies.

How similar studies have gone: Other EHR- and patient-portal recruitment efforts have shown promising but mixed results, and applying a randomized platform design to messaging strategies is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for primary studies that are recruiting participants:

* All studies using the MyChart recruitment service are eligible, including both clinical trials and observational studies.

Exclusion Criterion for primary studies that are recruiting participants:

* Not using MyChart for recruitment.
* At least 500 messages sent, 125 for each arm

Inclusion Criteria for patients:

* All patients receiving messages via MyChart will be included
* Potential eligibility for a study using MyChart requirement based on the planned query/criteria for that study.

Exclusion Criteria for patients:

* Minor
* Excluded from primary study that is recruiting participants.

Where it's running

  • Emory Healthcare System
    Atlanta, Georgia, United States
    Recruiting

Study contacts

  • Principal investigator: Neal Dickert, MD, PhD — Emory University
  • Study coordinator: Neal Dickert, MD, PhD
  • Email: njr@emory.edu
  • Phone: (404) 712-6834

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.